NRx Pharmaceuticals, Inc. (NRXP) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for NRx Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -2.03x | -0.92x | -1.16x | -18.36x | -24.10x | -2.58x |
| P/B Ratio | -3.64x | -1.00x | -2.97x | 98.53x | 107.79x | -3.05x |
| P/S Ratio | 47.35x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 47.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | -1324.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | -2336.5% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | -1309.8% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 0.31x | 0.15x | 0.36x | 1.66x | 2.74x | 0.06x |
| Quick Ratio | 0.31x | 0.15x | 0.36x | 1.66x | 2.74x | 0.06x |
| Leverage | ||||||
| Debt/Equity | -0.04x | -0.28x | -0.78x | 1.42x | 0.02x | -0.02x |
YoY = year-over-year change. Source: FMP..